Cargando…

Cooperation Between the Inflammation and Coagulation Systems Promotes the Survival of Circulating Tumor Cells in Renal Cell Carcinoma Patients

Most renal cell carcinoma (RCC) patients die from metastasis or recurrence after the spread of cancer to another organ, but the mechanisms underlying the intravascular survival of circulating tumor cells (CTCs) have not been completely deciphered. Additionally, although elevated plasma C-reactive pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wen, Li, Guo, Liping, Zhang, Wen, Li, Yajian, Jiang, Weixing, Di, Xuebing, Ma, JianHui, Feng, Lin, Zhang, Kaitai, Shou, Jianzhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590108/ https://www.ncbi.nlm.nih.gov/pubmed/31263677 http://dx.doi.org/10.3389/fonc.2019.00504

Ejemplares similares

Characteristics, dynamic changes, and prognostic significance of TCR repertoire profiling in patients with renal cell carcinoma
por: Guo, Liping, et al.
Publicado: (2020)

Prognostic Significance of NLR About NETosis and Lymphocytes Perturbations in Localized Renal Cell Carcinoma With Tumor Thrombus
por: Shang, Bingqing, et al.
Publicado: (2021)

Prospective Exploratory Study of the Clinical Significance of Circulating Tumor Cells in Patients With Small Cell Lung Cancer Exposed to Prophylactic Cranial Irradiation
por: Deng, Lei, et al.
Publicado: (2021)

Single nucleotide variant profiles of viable single circulating tumour cells reveal CTC behaviours in breast cancer
por: Wang, Yipeng, et al.
Publicado: (2018)

Copy Number Variations of CEP63, FOSL2 and PAQR6 Serve as Novel Signatures for the Prognosis of Bladder Cancer
por: Cai, Zhao, et al.
Publicado: (2021)

Impact of Primary Tumor Size on Prognosis in Patients With Metastatic Renal Cell Carcinoma Receiving Cytoreductive Nephrectomy: A Population Study of a Chinese Center and the US SEER Database
por: Jiang, Weixing, et al.
Publicado: (2021)

Do circulating tumor cells play a role in coagulation and thrombosis?
por: Tormoen, Garth W., et al.
Publicado: (2012)

Development of Coagulation Factor Probes for the Identification of Procoagulant Circulating Tumor Cells
por: Tormoen, Garth W., et al.
Publicado: (2012)

Case report: Capillary hemangioma in the renal hilum mimicking paraganglioma
por: Jiang, Weixing, et al.
Publicado: (2022)

Improving the diagnosis of prostate cancer by telomerase-positive circulating tumor cells: A prospective pilot study
por: Yang, Zhenrong, et al.
Publicado: (2022)

Prognostic value of the ratio of maximum to minimum diameter of primary tumor in metastatic clear cell renal cell carcinoma
por: Shi, Hongzhe, et al.
Publicado: (2022)

Anlotinib for Patients With Metastatic Renal Cell Carcinoma Previously Treated With One Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitor: A Phase 2 Trial
por: Ma, Jianhui, et al.
Publicado: (2020)

A signature for pan-cancer prognosis based on neutrophil extracellular traps
por: Zhang, Yi, et al.
Publicado: (2022)

Circulating Tumor Cells in Renal Cell Carcinoma: Recent Findings and Future Challenges
por: Santoni, Matteo, et al.
Publicado: (2019)

Aneuploid subtypes of circulating tumor cells and circulating tumor-derived endothelial cells predict the overall survival of advanced lung cancer
por: Zhang, Jie, et al.
Publicado: (2023)

Combination of Hematology Indicators and Oncological Characteristics as a New Promising Prognostic Factor in Localized Clear Cell Renal Cell Carcinoma
por: Kang, Xiangpeng, et al.
Publicado: (2020)

Effect of Severity of Liver Cirrhosis on Surgical Outcomes of Hepatocellular Carcinoma After Liver Resection and Microwave Coagulation
por: Li, Jiang, et al.
Publicado: (2021)

Novel cut‐off values of time from diagnosis to systematic therapy predict the overall survival and the efficacy of targeted therapy in renal cell carcinoma: A long‐term, follow‐up, retrospective study
por: Cao, Chuanzhen, et al.
Publicado: (2021)

A novel nomogram can predict pathological T3a upstaged from clinical T1a in localized renal cell carcinoma
por: Cao, Chuanzhen, et al.
Publicado: (2022)

Identification of an Autophagy-Related Prognostic Signature for Clear Cell Renal Cell Carcinoma
por: Chen, Mei, et al.
Publicado: (2020)

Comprehensive Genomic Landscape in Chinese Clear Cell Renal Cell Carcinoma Patients
por: Huang, Jiwei, et al.
Publicado: (2021)

Automated Classification of Papillary Renal Cell Carcinoma and Chromophobe Renal Cell Carcinoma Based on a Small Computed Tomography Imaging Dataset Using Deep Learning
por: Zuo, Teng, et al.
Publicado: (2021)

Impact of changing treatment strategy based on circulating tumor cells on postoperative survival of breast cancer
por: Wang, Zihan, et al.
Publicado: (2022)

Circulating tumor cells in the pulmonary vein increase significantly after lobectomy: A prospective observational study
por: Duan, Xinchun, et al.
Publicado: (2018)

Circulating Tumor Cells for Glioma
por: Zhang, Huikai, et al.
Publicado: (2021)

Impact of interaction networks of B cells with other cells on tumorigenesis, progression and response to immunotherapy of renal cell carcinoma: A review
por: Wang, Yu-qi, et al.
Publicado: (2022)

Long-term survival and prognostic factors for locally advanced renal cell carcinoma with renal vein tumor thrombus
por: Cao, Chuanzhen, et al.
Publicado: (2019)

Telomere Length of Circulating Cell-Free DNA and Gastric Cancer in a Chinese Population at High-Risk
por: Shi, Yu, et al.
Publicado: (2019)

An exploratory study of CT radiomics using differential network feature selection for WHO/ISUP grading and progression-free survival prediction of clear cell renal cell carcinoma
por: Yin, Fu, et al.
Publicado: (2022)

Neutrophil extracellular traps-associated modification patterns depict the tumor microenvironment, precision immunotherapy, and prognosis of clear cell renal cell carcinoma
por: Teng, Zhi-Hai, et al.
Publicado: (2022)

Coagulation Factor XIII Subunit A Is a Biomarker for Curative Effects and Prognosis in Malignant Solid Tumors, Especially Non-small Cell Lung Cancer
por: Luo, Yujiao, et al.
Publicado: (2021)

The Fib-PNI-MLR Score, an Integrative Model of Coagulation Cascades, Nutrition Status, and Systemic Inflammatory Response, Predicts Urological Outcomes After Surgery in Patients With Non-Metastatic Renal Cell Carcinoma
por: Gao, Xiaomin, et al.
Publicado: (2021)

Association of Inflammation-Related Gene Polymorphisms With Susceptibility and Radiotherapy Sensitivity in Head and Neck Squamous Cell Carcinoma Patients in Northeast China
por: Li, Ying, et al.
Publicado: (2021)

The Value of Circulating Tumor Cells in the Prognosis and Treatment of Pancreatic Cancer
por: Luo, Kai, et al.
Publicado: (2022)

The Diagnostic and Immunotherapeutic Value of CD248 in Renal Cell Carcinoma
por: Zhang, Keying, et al.
Publicado: (2021)

Germline Mutation Landscape and Associated Clinical Characteristics in Chinese Patients With Renal Cell Carcinoma
por: Kong, Wen, et al.
Publicado: (2021)

Clinical Utility of Circulating Tumor Cells in Patients With Esophageal Cancer
por: Li, Yang, et al.
Publicado: (2022)

Circulating MicroRNAs as Quantitative Biomarkers for Diagnosis and Prognosis of Uveal Melanoma
por: Zhou, Wen-Da, et al.
Publicado: (2022)

Mitochondrial metabolic reprogramming-mediated immunogenic cell death reveals immune and prognostic features of clear cell renal cell carcinoma
por: Yang, Lin, et al.
Publicado: (2023)

Prognostic significance of sarcopenia and systemic inflammation for patients with renal cell carcinoma following nephrectomy
por: Liu, Qiuchen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1q9eujbmgilqdkkihi4mvc8v5v